Work

Abstract 1767: Preclinical efficacy of a first-in-class anti-SLC3A2 ADC in hard-to-treat solid and hematologic malignancies

Year: 2026
Type: conference-abstract
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W7148687468
Cites:
Cited by:
Related to: